EUCTR2013-004987-80-BE进行中（未招募）不适用
Colistin use in Cystic Fibrosis patients: pharmacokinetic studies (intravenous administration) in relation with pharmacodynamics, tolerance profile and risk of selection of resistance.
CUB - Hôpital Erasme0 个研究点开始时间: 2014年2月18日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. CF patients aged of > 18 years
- •2. BMI > 18 kg/m2,
- •3. P. aeruginosa positive exacerbations,
- •4. requiring IV antibiotics including colistin
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 100
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. chronic renal insufficiency,
- •2. pregnancy or lactation,
- •3. no IV antibiotics in the month prior to inclusion.
研究者
相似试验
进行中（未招募）
1 期
Treatment of patients with cystic fibrosis with N-acetylcysteineEUCTR2007-001401-15-DKRigshospitalet
进行中（未招募）
不适用
Probiotics in Cystic Fibrosis - NDEUCTR2009-011289-27-ITIVERSITA` DEGLI STUDI DI NAPOLI FEDERICO II
已完成
不适用
Observation of the treatment of cystic fibrosis patients with Pseudomonas aeruginosa lung infection with ColiFin 1Mio I.E. or ColiFin 2Mio I.E.Chronic infection with Pseudomonas aeruginosaCystic fibrosisE84B96.5Pseudomonas (aeruginosa) as the cause of diseases classified to other chaptersCystic fibrosisDRKS00009540PARI Pharma GmbH32
进行中（未招募）
不适用
Azole Therapy in Cystic Fibrosis (ATCF)Cystic fibrosisMedDRA version: 14.1Level: PTClassification code 10011762Term: Cystic fibrosisSystem Organ Class: 10010331 - Congenital, familial and genetic disordersMedDRA version: 14.1Level: HLTClassification code 10003486Term: Aspergillus infectionsSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-005799-41-GBCHU de Rennes (Rennes University Hospital Centre)150
招募中
不适用
Stratifying Cystic Fibrosis Patients Based on Intestinal Organoid Response To Different CFTR-modulatorsMucoviscidosisCystic FibrosisNL-OMON48963niversitair Medisch Centrum Utrecht75